ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,083Medicare Part D Prescriptions Filled, Including Refills

Rank: 19 out of 120

$617K Total Retail Price of All Prescriptions

Rank: 18 out of 120

520 Patients Receiving at Least One Drug in Part D
83% Patients 65 Years and Older
34% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Montana
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

8% of this provider’s 520 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

15% of this provider’s 520 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Montana
LEVOTHYROXINE SODIUM 526 419 92 1 1
SIMVASTATIN 446 360 97 2 2
LISINOPRIL 443 389 88 3 3
WARFARIN SODIUM 439 353 61 4 8
HYDROCODONE-ACETAMINOPHEN 373 202 71 S3 5 7
AMLODIPINE BESYLATE 334 292 55 6 5
HYDROCHLOROTHIAZIDE 295 290* 62 7 10
FUROSEMIDE 292 278 59 8 6
METOPROLOL TARTRATE 246 230 39 9 15
ATORVASTATIN CALCIUM 216 168 39 10 9
METFORMIN HCL 203 165 37 11 14
GABAPENTIN 193 133 33 12 16
OMEPRAZOLE 190 152 42 13 4
SERTRALINE HCL 186 152 25 14 20
TAMSULOSIN HCL 166 142 32 15 24
ATENOLOL 162 139 25 16 18
LOSARTAN POTASSIUM 138 119 31 17 11
POTASSIUM CHLORIDE 136 131* 28 18 12
TRAZODONE HCL 136 94 25 18 37
ALLOPURINOL 135 118 23 20 19
CLONAZEPAM 120 93 34 B 21 42
LORAZEPAM 111 47 21 B 22 21
ALENDRONATE SODIUM 101 101 18 23 27
METOPROLOL SUCCINATE 98 93* 22 24 13
ZOLPIDEM TARTRATE 91 65 33 25 22
ALPRAZOLAM 91 43 15 B 25 46
ADVAIR DISKUS 84 72 18 27 31
CITALOPRAM HBR 83 78* 14 28 17
SPIRIVA 81 76* 13 29 58
CARVEDILOL 77 65 13 30 25
ESCITALOPRAM OXALATE 75 70* 12 31 54
DIAZEPAM 75 51 15 B 31 145
NEXIUM 74 48 11 33 52
LANTUS SOLOSTAR 72 36 12 34 50
NAMENDA 71 <11 <11 35 51
TRIAMTERENE-HCTZ 69 <11 <11 36 29
TRAMADOL HCL 67 44 13 37 26
FLUTICASONE PROPIONATE 66 49 21 38 36
DILTIAZEM ER 65 60* 11 39 124
PREDNISONE 62 49 23 40 33
SPIRONOLACTONE 59 54* 15 41 34
CRESTOR 58 <11 <11 42 32
BENAZEPRIL HCL 56 51* 13 43 47
MORPHINE SULFATE ER 55 <11 <11 S2 44 71
MELOXICAM 55 36 19 44 44
ROPINIROLE HCL 53 <11 <11 46 72
VENTOLIN HFA 51 40 11 47 99
KLOR-CON M20 50 <11 <11 48 77
LOVASTATIN 50 <11 <11 48 60
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 30, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.